시장조사 보고서 : 세계의 신규 암진단 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측

■ 영문 제목 : Global Emerging Cancer Diagnostics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
	■ 상품코드 : GIR-AB0810 ■ 조사/발행회사 : Globalinforesearch ■ 발행일 : 2019년 1월 23일 ■ 페이지수 : 116 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세별도)

Single User (1명 열람용)	USD3,480 ⇒환산￦3,828,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,220 ⇒환산￦5,742,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD6,960 ⇒환산￦7,656,000	견적의뢰/구입/질문

※가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.

본 조사보고서는 신규 암진단의 세계시장에 대해서 조사분석한 자료로서, 신규 암진단의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다.
・세계의 신규 암진단시장동향
・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율)
・주요 지역별 신규 암진단 시장분석/시장규모
　　- 북미시장 (미국, 캐나다, 멕시코)
　　- 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아)
　　- 아시아시장 (중국, 일본, 한국, 인도, 동남아시아)
　　- 남미시장 (브라질, 아르헨티나, 콜롬비아)
　　- 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카)
・신규 암진단의 종류별 시장분석/시장규모
・신규 암진단의 용도별 시장분석/시장규모
・신규 암진단의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측)
・신규 암진단의 판매채널, 유통업체 분석
...

■ 보고서 개요

Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation.

Scope of the Report:
The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Emerging Cancer Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Emerging Cancer Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Emerging Cancer Diagnostics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Abbott Laboratories
Danaher
Agilent Technologies
AstraZeneca
BD
Biocept
Illumina
Luminex
NeoGenomics
QIAGEN
Thermo Fisher Scientific

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Men
Women

Market Segment by Applications, can be divided into
Blood Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Others

■ 보고서 목차

Table of Contents

1 Emerging Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Emerging Cancer Diagnostics
1.2 Classification of Emerging Cancer Diagnostics by Types
1.2.1 Global Emerging Cancer Diagnostics Revenue Comparison by Types (2019-2024)
1.2.2 Global Emerging Cancer Diagnostics Revenue Market Share by Types in 2018
1.2.3 Men
1.2.4 Women
1.3 Global Emerging Cancer Diagnostics Market by Application
1.3.1 Global Emerging Cancer Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Global Emerging Cancer Diagnostics Market by Regions
1.4.1 Global Emerging Cancer Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Emerging Cancer Diagnostics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Emerging Cancer Diagnostics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Emerging Cancer Diagnostics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Emerging Cancer Diagnostics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Emerging Cancer Diagnostics Status and Prospect (2014-2024)
1.5 Global Market Size of Emerging Cancer Diagnostics (2014-2024)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Emerging Cancer Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Danaher
2.2.1 Business Overview
2.2.2 Emerging Cancer Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Danaher Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Emerging Cancer Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Emerging Cancer Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.5 BD
2.5.1 Business Overview
2.5.2 Emerging Cancer Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biocept
2.6.1 Business Overview
2.6.2 Emerging Cancer Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biocept Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Illumina
2.7.1 Business Overview
2.7.2 Emerging Cancer Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Illumina Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Luminex
2.8.1 Business Overview
2.8.2 Emerging Cancer Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Luminex Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.9 NeoGenomics
2.9.1 Business Overview
2.9.2 Emerging Cancer Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 NeoGenomics Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.10 QIAGEN
2.10.1 Business Overview
2.10.2 Emerging Cancer Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 QIAGEN Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Thermo Fisher Scientific
2.11.1 Business Overview
2.11.2 Emerging Cancer Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Emerging Cancer Diagnostics Market Competition, by Players
3.1 Global Emerging Cancer Diagnostics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Emerging Cancer Diagnostics Players Market Share
3.2.2 Top 10 Emerging Cancer Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Emerging Cancer Diagnostics Market Size by Regions
4.1 Global Emerging Cancer Diagnostics Revenue and Market Share by Regions
4.2 North America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
4.3 Europe Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
4.5 South America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
5 North America Emerging Cancer Diagnostics Revenue by Countries
5.1 North America Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
5.2 USA Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
5.3 Canada Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
5.4 Mexico Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
6 Europe Emerging Cancer Diagnostics Revenue by Countries
6.1 Europe Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
6.2 Germany Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
6.3 UK Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
6.4 France Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
6.5 Russia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
6.6 Italy Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Emerging Cancer Diagnostics Revenue by Countries
7.1 Asia-Pacific Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
7.2 China Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
7.3 Japan Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
7.4 Korea Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
7.5 India Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
8 South America Emerging Cancer Diagnostics Revenue by Countries
8.1 South America Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
8.2 Brazil Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
8.3 Argentina Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
8.4 Colombia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Emerging Cancer Diagnostics by Countries
9.1 Middle East and Africa Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
9.3 UAE Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
9.4 Egypt Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
9.6 South Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
10 Global Emerging Cancer Diagnostics Market Segment by Type
10.1 Global Emerging Cancer Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Global Emerging Cancer Diagnostics Market Forecast by Type (2019-2024)
10.3 Men Revenue Growth Rate (2014-2024)
10.4 Women Revenue Growth Rate (2014-2024)
11 Global Emerging Cancer Diagnostics Market Segment by Application
11.1 Global Emerging Cancer Diagnostics Revenue Market Share by Application (2014-2019)
11.2 Emerging Cancer Diagnostics Market Forecast by Application (2019-2024)
11.3 Blood Cancer Revenue Growth (2014-2019)
11.4 Prostate Cancer Revenue Growth (2014-2019)
11.5 Breast Cancer Revenue Growth (2014-2019)
11.6 Lung Cancer Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Emerging Cancer Diagnostics Market Size Forecast (2019-2024)
12.1 Global Emerging Cancer Diagnostics Market Size Forecast (2019-2024)
12.2 Global Emerging Cancer Diagnostics Market Forecast by Regions (2019-2024)
12.3 North America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
12.4 Europe Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
12.6 South America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Emerging Cancer Diagnostics Picture
Table Product Specifications of Emerging Cancer Diagnostics
Table Global Emerging Cancer Diagnostics and Revenue (Million USD) Market Split by Product Type
Figure Global Emerging Cancer Diagnostics Revenue Market Share by Types in 2018
Figure Men Picture
Figure Women Picture
Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Application (2014-2024)
Figure Emerging Cancer Diagnostics Revenue Market Share by Applications in 2018
Figure Blood Cancer Picture
Figure Prostate Cancer Picture
Figure Breast Cancer Picture
Figure Lung Cancer Picture
Figure Others Picture
Table Global Market Emerging Cancer Diagnostics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Emerging Cancer Diagnostics Type and Applications
Table Abbott Laboratories Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Danaher Basic Information, Manufacturing Base and Competitors
Table Danaher Emerging Cancer Diagnostics Type and Applications
Table Danaher Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Emerging Cancer Diagnostics Type and Applications
Table Agilent Technologies Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Emerging Cancer Diagnostics Type and Applications
Table AstraZeneca Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Emerging Cancer Diagnostics Type and Applications
Table BD Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Biocept Basic Information, Manufacturing Base and Competitors
Table Biocept Emerging Cancer Diagnostics Type and Applications
Table Biocept Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Emerging Cancer Diagnostics Type and Applications
Table Illumina Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Luminex Basic Information, Manufacturing Base and Competitors
Table Luminex Emerging Cancer Diagnostics Type and Applications
Table Luminex Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table NeoGenomics Basic Information, Manufacturing Base and Competitors
Table NeoGenomics Emerging Cancer Diagnostics Type and Applications
Table NeoGenomics Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Emerging Cancer Diagnostics Type and Applications
Table QIAGEN Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Emerging Cancer Diagnostics Type and Applications
Table Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Players (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue Share by Players (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Share by Players in 2017
Figure Global Emerging Cancer Diagnostics Revenue Share by Players in 2018
Figure Global Top 5 Players Emerging Cancer Diagnostics Revenue Market Share in 2018
Figure Global Top 10 Players Emerging Cancer Diagnostics Revenue Market Share in 2018
Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Regions (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue Market Share by Regions (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Market Share by Regions (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Market Share by Regions in 2018
Figure North America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Europe Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure South America Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table North America Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
Table North America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure North America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure North America Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure USA Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Canada Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Mexico Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table Europe Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Europe Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure Germany Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure UK Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure France Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Russia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Italy Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure China Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Japan Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Korea Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure India Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table South America Emerging Cancer Diagnostics Revenue by Countries (2014-2019)
Table South America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure South America Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure South America Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure Brazil Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Argentina Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Colombia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Emerging Cancer Diagnostics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure UAE Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Egypt Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure Nigeria Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Figure South Africa Emerging Cancer Diagnostics Revenue and Growth Rate (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue (Million USD) by Type (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue Share by Type (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Share by Type (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Share by Type in 2019
Table Global Emerging Cancer Diagnostics Revenue Forecast by Type (2019-2024)
Figure Global Emerging Cancer Diagnostics Market Share Forecast by Type (2019-2024)
Figure Global Men Revenue Growth Rate (2014-2019)
Figure Global Women Revenue Growth Rate (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue by Application (2014-2019)
Table Global Emerging Cancer Diagnostics Revenue Share by Application (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Share by Application (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue Share by Application in 2019
Table Global Emerging Cancer Diagnostics Revenue Forecast by Application (2019-2024)
Figure Global Emerging Cancer Diagnostics Market Share Forecast by Application (2019-2024)
Figure Global Blood Cancer Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Emerging Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Emerging Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Emerging Cancer Diagnostics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
Figure Europe Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
Figure South America Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Emerging Cancer Diagnostics Revenue Market Forecast (2019-2024)

※본 조사보고서 [세계의 신규 암진단 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] (코드 : GIR-AB0810) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 신규 암진단 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요.

[이하, 관련 보고서 소개]

세계의 순환 종양세포 (CTC) 및 암 줄기 세포 (CSCs) 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-AA1678 / Globalinforesearch / 2019년 2월 22일 / 본 조사보고서는 순환 종양세포 (CTC) 및 암 줄기 세포 (CSCs)의 세계시장에 대해서 조사분석한 자료로서, 순환 종양세포 (CTC) 및 암 줄기 세포 (CSCs)의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미,...Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of...

면역항암제의 세계시장 예측 : 제품별, 기술별, 질환별, 용도별
MD 6896 / MarketsandMarkets / 2019年2月14日 / 본 조사보고서는 면역항암제의 세계시장에 대해서 조사분석한 자료로서, 면역항암제의 세계시장규모, 시장동향, 산업동향, 시장환경 분석, 세그멘트별 분석, 지역별 분석 (미국, 유럽, 아시아등), 경쟁기업 정보등이 포함되어 있습니다....“The increasing adoption of targeted therapy over traditional therapy is expected to drive the overall growth of the immuno-oncology assays market.”The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The...

세계의 갑상선암 (ATC) 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-A-10394 / Globalinforesearch / 2019년 1월 17일 / 본 조사보고서는 갑상선암 (ATC)의 세계시장에 대해서 조사분석한 자료로서, 갑상선암 (ATC)의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 갑상선암 (ATC)시장동향 ・관련기업...Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Scope of the Report: The worldwide market for Anaplastic Thyroid Cancer is expected to grow at a CAGR of roughly xx% over...

세계의 갑상선암 (ATC) 치료법 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-A-10395 / Globalinforesearch / 2019년 1월 17일 / 본 조사보고서는 갑상선암 (ATC) 치료법의 세계시장에 대해서 조사분석한 자료로서, 갑상선암 (ATC) 치료법의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 갑상선암...Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Scope of the Report: The worldwide market for Anaplastic Thyroid Cancer Therapeutics is expected to grow at a CAGR of roughly xx%...

세계의 갑상선암 (ATC) 치료 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-A-10396 / Globalinforesearch / 2019년 1월 17일 / 본 조사보고서는 갑상선암 (ATC) 치료의 세계시장에 대해서 조사분석한 자료로서, 갑상선암 (ATC) 치료의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 갑상선암...Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Scope of the Report: The worldwide market for Anaplastic Thyroid Cancer Treatment is expected to grow at a CAGR of roughly xx%...

세계의 암 치료용 체크포인트 억제제 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-AA1585 / Globalinforesearch / 2019년 3월 26일 / 본 조사보고서는 암 치료용 체크포인트 억제제의 세계시장에 대해서 조사분석한 자료로서, 암 치료용 체크포인트 억제제의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다....Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins...

세계의 유방암 진단 검사 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-AA1223 / Globalinforesearch / 2019년 3월 14일 / 본 조사보고서는 유방암 진단 검사의 세계시장에 대해서 조사분석한 자료로서, 유방암 진단 검사의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 유방암...Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging. Scope of the Report: The top...

세계의 항암치료제 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-AA1356 / Globalinforesearch / 2019년 2월 18일 / 본 조사보고서는 항암치료제의 세계시장에 대해서 조사분석한 자료로서, 항암치료제의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 항암치료제시장동향 ・관련기업 개요 (사업개요, 제품종류,...Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the...

세계의 순환 종양세포 (CTC) 시장 2019 : 제조사별, 지역별, 종류/용도별, 시장예측
GIR-AA1679 / Globalinforesearch / 2019년 3월 5일 / 본 조사보고서는 순환 종양세포 (CTC)의 세계시장에 대해서 조사분석한 자료로서, 순환 종양세포 (CTC)의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다. ・세계의 순환...Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding...

유방 영상 기술의 세계시장 예측 : 기술별 (전리/비전리)
MD 2554 / MarketsandMarkets / 2019년 1월 23일 / 본 조사보고서는 유방 영상 기술의 세계시장에 대해서 조사분석한 자료로서, 유방 영상 기술의 세계시장규모, 시장동향, 산업동향, 시장환경 분석, 세그멘트별 분석, 지역별 분석 (미국, 유럽, 아시아등), 경쟁기업 정보등이 포함되어 있습니다....“The breast imaging market is projected to grow at a CAGR of 8.0% during the forecast period”The global breast imaging market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8.0%. Growth in this market is largely driven by factors...